doi: 10.1016/0010-4825(92)90011-b.
MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring
Affiliations
- PMID: 1617949
- DOI: 10.1016/0010-4825(92)90011-b
Item in Clipboard
MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring
Comput Biol Med.
1992 May.
Abstract
The pharmacokinetic software package MW/Pharm offers an interactive, user-friendly program which gives rapid answers in clinical practice. It comprises a database with pharmacokinetic parameters of 180 drugs, a medication history database, and procedures for an individual drug dosage regimen calculation. The included curve-fitting facilities allow estimation of pharmacokinetic parameters on the basis of medication history, taking into account a varying status of the patient with respect to body weight and kidney function, optionally using a Bayesian procedure. The module KinBes performs the evaluation of bioavailability studies, including various methods, and an extensive statistical evaluation of bioequivalence.
Similar articles
-
Population kinetics and conditional assessment of the optimal dosage regimen using the P-PHARM software package.Anticancer Res. 1994 Nov-Dec;14(6A):2321-6. Anticancer Res. 1994. PMID: 7825966 Review.
-
Use of Bayesian methods for multivariate bioequivalence measures.J Biopharm Stat. 2009;19(1):42-66. doi: 10.1080/10543400802513676. J Biopharm Stat. 2009. PMID: 19127466
-
PHARM--an interactive graphic program for individual and population pharmacokinetic parameter estimation.Comput Biol Med. 1984;14(1):25-34. doi: 10.1016/0010-4825(84)90017-9. Comput Biol Med. 1984. PMID: 6546907
-
Individualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, Bayesian fitting, and adaptive control.Ther Drug Monit. 1993 Oct;15(5):380-93. Ther Drug Monit. 1993. PMID: 8249044 Review.
-
APIS: a software for model identification, simulation and dosage regimen calculations in clinical and experimental pharmacokinetics.Comput Methods Programs Biomed. 1992 Aug;38(4):227-39. doi: 10.1016/0169-2607(92)90103-e. Comput Methods Programs Biomed. 1992. PMID: 1473342 Clinical Trial.
Cited by
-
A semi-mechanistic model based on glutathione depletion to describe intra-individual reduction in busulfan clearance.Br J Clin Pharmacol. 2020 Aug;86(8):1499-1509. doi: 10.1111/bcp.14256. Epub 2020 Mar 10. Br J Clin Pharmacol. 2020. PMID: 32067250 Free PMC article.
-
Carboplatin dosage formulae can generate inaccurate predictions of Carboplatin exposure in carboplatin/paclitaxel combination regimens.Clin Drug Investig. 1998;15(4):327-35. doi: 10.2165/00044011-199815040-00009. Clin Drug Investig. 1998. PMID: 18370488
-
Evaluation of Target Attainment of Vancomycin Area Under the Curve in Children With Methicillin-Resistant Staphylococcus Aureus Bacteremia.Ther Drug Monit. 2015 Oct;37(5):619-25. doi: 10.1097/FTD.0000000000000190. Ther Drug Monit. 2015. PMID: 26378371 Free PMC article.
-
Pharmacokinetic modelling to predict risk of ototoxicity with intravenous tobramycin treatment in cystic fibrosis.J Antimicrob Chemother. 2021 Oct 11;76(11):2923-2931. doi: 10.1093/jac/dkab288. J Antimicrob Chemother. 2021. PMID: 34379758 Free PMC article.
-
Rationale, Development, and Validation of HdxSim, a Clinical Decision Support Tool for Model-Informed Precision Dosing of Hydroxyurea for Children with Sickle Cell Anemia.Clin Pharmacol Ther. 2024 Sep;116(3):670-677. doi: 10.1002/cpt.3119. Epub 2023 Dec 18. Clin Pharmacol Ther. 2024. PMID: 38018175
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
